Herpesviruses encode a proteinase that functions during assembly and maturation of the capsid and that is essential for the production of infectious virus (13,17,24,31,41,42,53,55). The human cytomegalovirus (HCMV) homolog is synthesized as an enzymatically active 74-kDa precursor that cleaves itself at two consensus sequences called the maturational (M) and release (R) sites (Fig. 1), which have counterparts among all herpesviruses (1,12,20,55). M-site cleavage of the HCMV precursor eliminates its 6-kDa carboxyl "tail," which mediates interaction with the major capsid protein (MCP; pUL86) at the earliest stages of subunit organization and capsid assembly (2, 37, 56). R-site cleavage releases the 28-kDa amino proteolytic domain from the carboxyl portion of the precursor, which targets the proteinase to its site of action within nascent intranuclear capsids (30,39,55,56). The crystal structure of the proteolytic domain, called assemblin, established it as the prototype of a new clan of serine proteinases, distinguished by their Ser-His-His (rather than Ser-His-Asp/Glu) catalytic triad and different protein folds (7,43,46,51). Assemblin is activated by dimerization (8,9,32) to constitute an enzyme with two separate catalytic sites and poor catalytic efficiency compared to other serine proteinases (38,44,48,50,53).In addition to the M and R sites common to the herpesvirus group, the HCMV proteinase has internal (I) and cryptic (C) cleavage sites within assemblin ( Fig. 1) (1, 5, 28, 54). The I site has a recognized consensus sequence among other cytomegalovirus (CMV) homologs and has received comparatively more attention than the C site, which may be restricted to HCMV. The I site is located near the middle of assemblin, between Ser132 and His157 of the catalytic triad, yet its cleavage has no detected effect on the proteolytic behavior of the enzyme (22,25,28,36), in contrast to the inactivating D-site cleavage of the Kaposi's sarcoma herpesvirus, human herpesvirus 8 (40). Furthermore, enzymatic activity can be constituted by coexpressing the separately cloned coding sequences for the two I-site cleavage fragments, A n and A c (22, 23), or by combining the independently expressed fragments in vitro (36). Moreover, an enzymatically active form of the herpes simplex virus (HSV) assemblin homolog, which has no I site, can be constituted by coexpressing the HSV sequences that are counterparts to CMV A n and A c (21). Thus, the significance of I-site cleavage has not been revealed by studies of the cloned enzyme expressed and tested in the absence of other viral proteins. The work described here was done to test the requirement for I-site cleavage in the context of virus-infected cells by constructing and studying a mutant HCMV encoding a defective I site. Phenotypic characterizations were done to compare the I-site mutant and wild-type virus with respect to cytopathic effect (CPE), yield of infectious virus and noninfectious extracellular particles, I-site cleavage, and incorporation of the proteinase into virus parti...